Tumor microenvironment is multifaceted

Cancer and Metastasis Reviews

Volumn 30, Issue 1, 2011, Pages 13-25

  Sautès Fridman, Catherine ^a,b,c   Cherfils Vicini, Julien ^a,b,c,f   Damotte, Diane ^a,b,c,d   Fisson, Sylvain ^a,b,c   Fridman, Wolf Hervé ^a,b,c,e   Cremer, Isabelle ^a,b,c   Dieu Nosjean, Marie Caroline ^a,b,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔTEL DIEU   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

Author keywords

Adaptive immunity; Brain; Dendritic cell; Eye; Immune response; Lung cancer; Lymphoma; Metastasis; Tertiary lymphoid structure; TLR; Tumor microenvironment

Indexed keywords

TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CELL DENSITY; CELL INFILTRATION; CELL MATURATION; CELL STIMULATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; DENDRITIC CELL; GENE EXPRESSION PROFILING; HUMAN; IMMUNOCOMPETENT CELL; LANGERHANS CELL; LEYDIG CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CENTRAL NERVOUS SYSTEM; DENDRITIC CELLS; HUMANS; LYMPHOMA; TOLL-LIKE RECEPTORS; TUMOR MICROENVIRONMENT;

EID: 79952281705     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-011-9279-y     Document Type: Article

References (95)

1. F Balkwill 2009 Tumour necrosis factor and cancer Nature Reviews Cancer 9 361 371 19343034 10.1038/nrc2628 1:CAS:528:DC%2BD1MXjvF2gtLk%3D
2. H Ohshima M Tatemichi T Sawa 2003 Chemical basis of inflammation-induced carcinogenesis Archives of Biochemistry and Biophysics 417 3 11 12921773 10.1016/S0003-9861(03)00283-2 1:CAS:528:DC%2BD3sXmt1WrtLg%3D (Pubitemid 36960042)
3. M Karin FR Greten 2005 NF-kappaB: linking inflammation and immunity to cancer development and progression Nature Reviews Immunology 5 749 759 16175180 10.1038/nri1703 1:CAS:528:DC%2BD2MXhtVGrurvL (Pubitemid 41400849)
4. W-W Lin M Karin 2007 A cytokine-mediated link between innate immunity, inflammation, and cancer Journal of Clinical Investigation 117 1175 1183 17476347 10.1172/JCI31537 1:CAS:528:DC%2BD2sXlt1Omtrk%3D (Pubitemid 46718402)
5. F Balkwill A Mantovani 2001 Inflammation and cancer: back to Virchow? Lancet 357 539 545 11229684 10.1016/S0140-6736(00)04046-0 1:CAS:528: DC%2BD3MXhsVKltb0%3D (Pubitemid 32173595)
6. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 12490959 10.1038/nature01322 1:CAS:528:DC%2BD38XpsFygtb4%3D (Pubitemid 36019639)
7. E Tartour S Latour C Mathiot N Thiounn V Mosseri I Joyeux CD D'Enghien R Lee B Debre WH Fridman 1995 Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function International Journal of Cancer 63 205 212 10.1002/ijc.2910630210 1:STN:280:DyaK28%2FktlOhug%3D%3D
8. I Frydecka P Kaczmarek D Boćko A Kosmaczewska R Morilla D Catovsky 1999 Expression of signal-transducing zeta chain in peripheral blood T cells and natural killer cells in patients with Hodgkin's disease in different phases of the disease Leukaemia & Lymphoma 35 545 554 10.1080/10428199909169619 1:CAS:528:DC%2BD3MXjt1egurs%3D (Pubitemid 30015654)
9. N Bronstein-Sitton L Cohen-Daniel I Vaknin AV Ezernitchi B Leshem A Halabi Y Houri-Hadad E Greenbaum Z Zakay-Rones L Shapira M Baniyash 2003 Sustained exposure to bacterial antigen induces interferon-gamma-dependent T cell receptor zeta down-regulation and impaired T cell function Nature Immunology 4 957 964 14502285 10.1038/ni975 1:CAS:528:DC%2BD3sXnsF2mu74%3D (Pubitemid 37270574)
10. J Cherfils-Vicini S Platonova M Gillard L Laurans P Validire R Caliandro P Magdeleinat F Mami-Chouaib M-C Dieu-Nosjean W-H Fridman D Damotte C Sautès-Fridman I Cremer 2010 Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance The Journal of Clinical Investigation 120 4 1285 1297 20237413 10.1172/JCI36551 1:CAS:528:DC%2BC3cXksVChsbY%3D
11. GP Dunn CM Koebel RD Schreiber 2006 Interferons, immunity and cancer immunoediting Nature Reviews Immunology 6 836 848 17063185 10.1038/nri1961 1:CAS:528:DC%2BD28XhtFWns7fK (Pubitemid 44631652)
12. M BURNET 1957 Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications British Medical Journal 1 841 847 13413231 10.1136/bmj.1.5023.841 1:STN:280:DyaG2s%2FlvFGqsA%3D%3D
13. J Galon A Costes F Sanchez-Cabo A Kirilovsky B Mlecnik C Lagorce-Pagès M Tosolini M Camus A Berger P Wind F Zinzindohoué P Bruneval P-H Cugnenc Z Trajanoski W-H Fridman F Pagès 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 1960 1964 17008531 10.1126/science.1129139 1:CAS:528:DC%2BD28XhtVSnsrnK (Pubitemid 44498003)
14. F Pagès A Berger M Camus F Sanchez-Cabo A Costes R Molidor B Mlecnik A Kirilovsky M Nilsson D Damotte T Meatchi P Bruneval P-H Cugnenc Z Trajanoski W-H Fridman J Galon 2005 Effector memory T cells, early metastasis, and survival in colorectal cancer The New England Journal of Medicine 353 2654 2666 16371631 10.1056/NEJMoa051424 (Pubitemid 41817714)
15. M-C Dieu-Nosjean M Antoine C Danel D Heudes M Wislez V Poulot N Rabbe L Laurans E Tartour L de Chaisemartin S Lebecque W-H Fridman J Cadranel 2008 Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures Journal of Clinical Oncology 26 4410 4417 18802153 10.1200/JCO.2007.15.0284 1:CAS:528:DC%2BD1cXht1ejur7F
16. Fridman, W. H., Galon, J., Dieu-Nosjean, M.-C., Cremer, I., Fisson, S., Damotte, D., Pagès, F., Tartour, E., Sautès-Fridman, C. (2010). Immune infiltration in human cancer: prognostic significance and disease control. Current topics in Microbiology and Immunology
17. J Banchereau RM Steinman 1998 Dendritic cells and the control of immunity Nature 392 245 252 9521319 10.1038/32588 1:CAS:528:DyaK1cXitFWrsr8%3D (Pubitemid 28155090)
18. E Klechevsky R Morita M Liu Y Cao S Coquery L Thompson-Snipes F Briere D Chaussabel G Zurawski AK Palucka Y Reiter J Banchereau H Ueno 2008 Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells Immunity 29 497 510 18789730 10.1016/j.immuni.2008.07.013 1:CAS:528:DC%2BD1cXhtF2jtLnP
19. C Ménétrier-Caux C Bain MC Favrot A Duc JY Blay 1999 Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes British Journal of Cancer 79 119 130 10408703 10.1038/sj.bjc.6690021 (Pubitemid 28566936)
20. B Almand JR Resser B Lindman S Nadaf JI Clark ED Kwon DP Carbone DI Gabrilovich 2000 Clinical significance of defective dendritic cell differentiation in cancer Clinical Cancer Research 6 1755 1766 10815894 1:STN:280:DC%2BD3cvhtVOhsw%3D%3D (Pubitemid 30305068)
21. BJ Coventry P-L Lee D Gibbs DNJ Hart 2002 Dendritic cell density and activation status in human breast cancer-CD1a, CMRF-44, CMRF-56 and CD-83 expression British Journal of Cancer 86 546 551 11870535 10.1038/sj.bjc.6600132 1:CAS:528:DC%2BD38XislCmtrs%3D (Pubitemid 34185090)
22. DI Gabrilovich HL Chen KR Girgis HT Cunningham GM Meny S Nadaf D Kavanaugh DP Carbone 1996 Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Natural Medicines 2 1096 1103 10.1038/nm1096-1096 1:CAS:528:DyaK28Xmt1Wnu7o%3D (Pubitemid 26338628)
23. M Movassagh A Spatz J Davoust S Lebecque P Romero M Pittet D Rimoldi D Liénard O Gugerli L Ferradini C Robert M-F Avril L Zitvogel E Angevin 2004 Selective accumulation of mature DC-Lamp∈+∈dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma Cancer Research 64 2192 2198 15026362 10.1158/0008-5472.CAN-03-2969 1:CAS:528:DC%2BD2cXitFCgu7o%3D (Pubitemid 38339472)
24. W Vermi R Bonecchi F Facchetti D Bianchi S Sozzani S Festa A Berenzi M Cella M Colonna 2003 Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas The Journal of Pathology 200 255 268 12754747 10.1002/path.1344 (Pubitemid 36748035)
25. D Bell P Chomarat D Broyles G Netto GM Harb S Lebecque J Valladeau J Davoust KA Palucka J Banchereau 1999 In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas The Journal of Experimental Medicine 190 1417 1426 10562317 10.1084/jem.190.10.1417 1:CAS:528:DyaK1MXnsVams7g%3D
26. M Furihata Y Ono K Ichikawa S Tomita T Fujimori K Kubota 2005 Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma Oncology Reports 14 353 356 16012714 1:CAS:528:DC%2BD2MXnslyqtLk%3D
27. T Schwaab JE Weiss AR Schned RJ Barth Jr 2001 Dendritic cell infiltration in colon cancer Journal of Immunotherapy 24 130 137 10.1097/00002371-200103000- 00007 1:STN:280:DC%2BD3M7msVGqtw%3D%3D (Pubitemid 32183059)
28. A Eisenthal N Polyvkin L Bramante-Schreiber F Misonznik A Hassner B Lifschitz-Mercer 2001 Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer Human Pathology 32 803 807 11521223 10.1053/hupa.2001.26455 1:STN:280:DC%2BD3Mvnslaltw%3D%3D (Pubitemid 32803980)
29. TE Reichert C Scheuer R Day W Wagner TL Whiteside 2001 The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma Cancer 91 2136 2147 11391595 10.1002/1097-0142(20010601)91:11<2136::AID-CNCR1242>3.0.CO;2-Q 1:CAS:528:DC%2BD3MXktlyjur0%3D (Pubitemid 32476379)
30. I Treilleux J-Y Blay N Bendriss-Vermare I Ray-Coquard T Bachelot J-P Guastalla A Bremond S Goddard J-J Pin C Barthelemy-Dubois S Lebecque 2004 Dendritic cell infiltration and prognosis of early stage breast cancer Clinical Cancer Research 10 7466 7474 15569976 10.1158/1078-0432.CCR-04-0684 1:CAS:528:DC%2BD2cXhtVanur7K (Pubitemid 39561754)
31. S Vallabhapurapu M Karin 2009 Regulation and function of NF-kappaB transcription factors in the immune system Annual Review of Immunology 27 693 733 19302050 10.1146/annurev.immunol.021908.132641 1:CAS:528: DC%2BD1MXlsFSlt7o%3D
32. X Li S Jiang R Tapping 2010 Toll-like receptor signaling in cell proliferation and survival Cytokine 49 40422
33. S Rakoff-Nahoum R Medzhitov 2007 Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88 Science 317 124 127 17615359 10.1126/science.1140488 1:CAS:528:DC%2BD2sXnt1Sjtb4%3D (Pubitemid 47056471)
34. H Xiao MF Gulen J Qin J Yao K Bulek D Kish CZ Altuntas D Wald C Ma H Zhou VK Tuohy RL Fairchild C de la Motte D Cua BA Vallance X Li 2007 The toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis Immunity 26 461 475 17398123 10.1016/j.immuni.2007.02.012 1:CAS:528:DC%2BD2sXltVKjs7w%3D (Pubitemid 46602997)
35. B Huang J Zhao JC Unkeless ZH Feng H Xiong 2008 TLR signaling by tumor and immune cells: a double-edged sword Oncogene 27 218 224 18176603 10.1038/sj.onc.1210904 1:CAS:528:DC%2BD1cXitl2huw%3D%3D
36. M Ikebe Y Kitaura M Nakamura H Tanaka A Yamasaki S Nagai J Wada K Yanai K Koga N Sato M Kubo M Tanaka H Onishi M Katano 2009 Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway Journal of Surgical Oncology 100 8 725 731 19722233 10.1002/jso.21392 1:CAS:528:DC%2BC3cXht1agsr0%3D
37. SD Killeen JH Wang EJ Andrews HP Redmond 2006 Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? British Journal of Cancer 95 247 252 16892041 10.1038/sj.bjc.6603275 1:CAS:528:DC%2BD28Xnsl2hs74%3D (Pubitemid 44187583)
38. MG Kelly AB Alvero R Chen D-A Silasi VM Abrahams S Chan I Visintin T Rutherford G Mor 2006 TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer Cancer Research 66 3859 3868 16585214 10.1158/0008-5472.CAN-05-3948 1:CAS:528:DC%2BD28XjtVOru7k%3D
39. M Szajnik M Szczepanski M Czystowska E Elishaev M Mandapathil E Nowak-Markwitz M Spaczynski T Whiteside 2009 TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer Oncogene 28 4353 4363 19826413 10.1038/onc.2009.289 1:CAS:528:DC%2BD1MXht1GlsrjN
40. W He Q Liu L Wang W Chen N Li X Cao 2007 TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance Molecular Immunology 44 2850 2859 10.1016/j.molimm.2007.01. 022 1:CAS:528:DC%2BD2sXjtVWrtrs%3D (Pubitemid 46412506)
41. B Huang J Zhao H Li K-L He Y Chen S-H Chen L Mayer JC Unkeless H Xiong 2005 Toll-like receptors on tumor cells facilitate evasion of immune surveillance Cancer Research 65 5009 5014 15958541 10.1158/0008-5472.CAN-05-0784 1:CAS:528:DC%2BD2MXltFemtLo%3D (Pubitemid 40827306)
42. B Jahrsdorfer L Mühlenhoff SE Blackwell M Wagner H Poeck E Hartmann R Jox T Giese B Emmerich S Endres GJ Weiner G Hartmann 2005 B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides Clinical Cancer Research 11 1490 1499 15746051 10.1158/1078-0432.CCR-04-1890 1:CAS:528:DC%2BD2MXhvVSrsbo%3D (Pubitemid 40315231)
43. B Salaun I Coste M-C Rissoan SJ Lebecque T Renno 2006 TLR3 can directly trigger apoptosis in human cancer cells Journal of Immunology 176 4894 4901 1:CAS:528:DC%2BD28XjtV2gtr0%3D
44. B Salaun S Lebecque S Matikainen D Rimoldi P Romero 2007 Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clinical Cancer Research 13 4565 4574 17671143 10.1158/1078-0432.CCR-07-0274 1:CAS:528:DC%2BD2sXotlGqu7g%3D (Pubitemid 47219727)
45. B Salaun P Romero S Lebecque 2007 Toll-like receptors' two-edged sword: when immunity meets apoptosis European Journal of Immunology 37 3311 3318 18034428 10.1002/eji.200737744 1:CAS:528:DC%2BD1cXhsVejsQ%3D%3D
46. K Chen J Huang W Gong P Iribarren NM Dunlop JM Wang 2007 Toll-like receptors in inflammation, infection and cancer International Immunopharmacology 7 1271 1285 17673142 10.1016/j.intimp.2007.05.016 1:CAS:528: DC%2BD2sXosF2qsr8%3D (Pubitemid 47126372)
47. AM Krieg 2007 Development of TLR9 agonists for cancer therapy Journal of Clinical Investigation 117 1184 1194 17476348 10.1172/JCI31414 1:CAS:528:DC%2BD2sXlt1OmtrY%3D (Pubitemid 46718403)
48. H Kumar T Kawai S Akira 2009 Pathogen recognition in the innate immune response The Biochemical Journal 420 1 16 19382893 10.1042/BJ20090272 1:CAS:528:DC%2BD1MXltFCjsLo%3D
49. M-F Tsan 2006 Toll-like receptors, inflammation and cancer Seminars in Cancer Biology 16 32 37 16153858 10.1016/j.semcancer.2005.07.004 1:CAS:528:DC%2BD28XotVCmtQ%3D%3D (Pubitemid 43139707)
50. H Kanzler FJ Barrat EM Hessel RL Coffman 2007 Therapeutic targeting of innate immunity with toll-like receptor agonists and antagonists Natural Medicines 13 552 559 10.1038/nm1589 1:CAS:528:DC%2BD2sXkvVOgsrs%3D (Pubitemid 46830615)
51. S Rakoff-Nahoum R Medzhitov 2009 Toll-like receptors and cancer Nature Reviews Cancer 9 57 63 19052556 10.1038/nrc2541 1:CAS:528:DC%2BD1cXhsVGlu77P
52. MP Schön M Schön 2008 TLR7 and TLR8 as targets in cancer therapy Oncogene 27 190 199 18176600 10.1038/sj.onc.1210913
53. AJ Littman LA Jackson TL Vaughan 2005 Chlamydia pneumoniae and lung cancer: epidemiologic evidence Cancer Epidemiol Biomarkers and Prevention 14 773 778 10.1158/1055-9965.EPI-04-0599 1:CAS:528:DC%2BD2MXjtFSktb0%3D (Pubitemid 40478534)
54. AJ Littman MD Thornquist E White LA Jackson GE Goodman TL Vaughan 2004 Prior lung disease and risk of lung cancer in a large prospective study Cancer Causes & Control 15 819 827 10.1023/B:CACO.0000043432.71626.45 (Pubitemid 39335578)
55. AJ Littman E White LA Jackson MD Thornquist CA Gaydos GE Goodman TL Vaughan 2004 Chlamydia pneumoniae infection and risk of lung cancer Cancer Epidemiol Biomarkers and Prevention 13 1624 1630 (Pubitemid 39331884)
56. M Philip DA Rowley H Schreiber 2004 Inflammation as a tumor promoter in cancer induction Seminars in Cancer Biology 14 433 439 15489136 10.1016/j.semcancer.2004.06.006 1:CAS:528:DC%2BD2cXos1Kkt7s%3D (Pubitemid 39360991)
57. J Qin J Yao G Cui H Xiao TW Kim J Fraczek P Wightman S Sato S Akira A Puel J-L Casanova B Su X Li 2006 TLR8-mediated NF-kappaB and JNK activation are TAK1-independent and MEKK3-dependent The Journal of Biological Chemistry 281 21013 21021 16737960 10.1074/jbc.M512908200 1:CAS:528:DC%2BD28Xnt1Gqur8%3D (Pubitemid 44115442)
58. B Huang J Zhao S Shen H Li K-L He G-X Shen L Mayer J Unkeless D Li Y Yuan G-M Zhang H Xiong Z-H Feng 2007 Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling Cancer Research 67 4346 4352 17483348 10.1158/0008-5472.CAN-06-4067 1:CAS:528:DC%2BD2sXltVyrsLc%3D (Pubitemid 46815083)
59. J-L Luo S Maeda L-C Hsu H Yagita M Karin 2004 Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression Cancer Cell 6 297 305 15380520 10.1016/j.ccr.2004.08.012 1:CAS:528:DC%2BD2cXot1KisL8%3D (Pubitemid 39222042)
60. L Sfondrini A Rossini D Besusso A Merlo E Tagliabue S Mènard A Balsari 2006 Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer Journal of Immunology 176 6624 6630 1:CAS:528:DC%2BD28XkslWhsr0%3D (Pubitemid 43787845)
61. T Earl I Nicoud J Pierce J Wright N Majoras J Rubin K Pierre D Gorden R Chari 2009 Silencing of TLR4 Decreases Liver Tumor Burden in a Murine Model of Colorectal Metastasis and Hepatic Steatosis Annals of Surgical Oncology 16 1043 1050 19165543 10.1245/s10434-009-0325-8 1:STN:280:DC%2BD1M7ptFCgsQ%3D%3D
62. A Tesniere F Schlemmer V Boige O Kepp I Martins F Ghiringhelli L Aymeric M Michaud L Apetoh L Barault J Mendiboure J-P Pignon V Jooste P van Endert M Ducreux L Zitvogel F Piard G Kroemer 2010 Immunogenic death of colon cancer cells treated with oxaliplatin Oncogene 29 482 491 19881547 10.1038/onc.2009.356 1:CAS:528:DC%2BD1MXhtlers7jL
63. D Chiron C Pellat-Deceunynck M Amiot R Bataille G Jego 2009 TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production Journal of Immunology 182 4471 4478 10.4049/jimmunol.0803113 1:CAS:528:DC%2BD1MXjsVSisr0%3D
64. Q Wang D Nagarkar E Bowman D Schneider B Gosangi J Lei Y Zhao C McHenry R Burgens D Miller U Sajjan M Hershenson 2009 Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses Journal of Immunology 183 6989 6997 10.4049/jimmunol.0901386 1:CAS:528:DC%2BD1MXhsVehsLfE
65. S Peng J Geng R Sun Z Tian H Wei 2008 Polyinosinic-polycytidylic acid liposome induces human hepatoma cells apoptosis which correlates to the up-regulation of RIG-I like receptors Cancer Science 100 529 536 19154402 10.1111/j.1349-7006.2008.01062.x
66. T Nakajima T Kodama M Tsumuraya Y Shimosato T Kameya 1985 S-100 protein-positive Langerhans cells in various human lung cancers, especially in peripheral adenocarcinomas Virchows Archiv. A, Pathological Anatomy and Histopathology 407 177 189 3927583 10.1007/BF00737075 1:STN:280: DyaL2M3nsVemtw%3D%3D (Pubitemid 15233455)
67. IK Demedts GG Brusselle KY Vermaelen RA Pauwels 2005 Identification and characterization of human pulmonary dendritic cells American Journal of Respiratory Cell and Molecular Biology 32 177 184 15576669 10.1165/rcmb.2004- 0279OC 1:CAS:528:DC%2BD2MXit1SrsL8%3D (Pubitemid 40387643)
68. A Tazi F Bouchonnet M Grandsaigne L Boumsell AJ Hance P Soler 1993 Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers The Journal of Clinical Investigation 91 566 576 7679411 10.1172/JCI116236 1:CAS:528:DyaK3sXhs1Oit7s%3D (Pubitemid 23064142)
69. C Asselin-Paturel C Pardoux F Gay S Chouaib 1998 Failure of TGF beta1 and IL-12 to regulate human FasL and mTNF alloreactive cytotoxic T-cell pathways Tissue Antigens 51 242 249 9550324 10.1111/j.1399-0039.1998.tb03098.x 1:CAS:528:DyaK1cXitFarsbY%3D (Pubitemid 28112458)
70. DA Arenberg MP Keane B DiGiovine SL Kunkel SR Strom MD Burdick MD Iannettoni RM Strieter 2000 Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines Cancer Immunology, Immunotherapy 49 63 70 10823415 10.1007/s002620050603 1:CAS:528:DC%2BD3cXktVyjtr4%3D (Pubitemid 30431641)
71. M Põld LX Zhu S Sharma MD Burdick Y Lin PPN Lee A Põld J Luo K Krysan M Dohadwala JT Mao RK Batra RM Strieter SM Dubinett 2004 Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer Cancer Research 64 1853 1860 14996749 10.1158/0008-5472.CAN-03-3262 (Pubitemid 38428711)
72. T Cao H Ueno C Glaser JW Fay AK Palucka J Banchereau 2007 Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL European Journal of Immunology 37 2657 2667 17683111 10.1002/eji.200636499 1:CAS:528:DC%2BD2sXhtFahsL%2FL (Pubitemid 47423633)
73. J Marchal-Sommé Y Uzunhan S Marchand-Adam D Valeyre V Soumelis B Crestani P Soler 2006 Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis Journal of Immunology 176 5735 5739
74. O Wakabayashi K Yamazaki S Oizumi F Hommura I Kinoshita S Ogura H Dosaka-Akita M Nishimura 2003 CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers Cancer Science 94 1003 1009 14611679 10.1111/j.1349-7006.2003. tb01392.x 1:CAS:528:DC%2BD2cXhsF2mtw%3D%3D (Pubitemid 37521216)
75. E Tartour A Gey X Sastre-Garau I Lombard Surin V Mosseri WH Fridman 1998 Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas Journal of the National Cancer Institute 90 287 294 9486814 10.1093/jnci/90.4.287 1:STN:280:DyaK1c7ks1aiuw%3D%3D (Pubitemid 28182384)
76. P Yu Y Lee W Liu RK Chin J Wang Y Wang A Schietinger M Philip H Schreiber Y-X Fu 2004 Priming of naive T cells inside tumors leads to eradication of established tumors Nature Immunology 5 141 149 14704792 10.1038/ni1029 1:CAS:528:DC%2BD2cXntFWnuw%3D%3D (Pubitemid 38208355)
77. CJ Kirk D Hartigan-O'Connor BJ Nickoloff JS Chamberlain M Giedlin L Aukerman JJ Mule 2001 T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy Cancer Research 61 2062 2070 11280767 1:CAS:528:DC%2BD3MXit1OgsLw%3D (Pubitemid 32692028)
78. JE Moyron-Quiroz J Rangel-Moreno K Kusser L Hartson F Sprague S Goodrich DL Woodland FE Lund TD Randall 2004 Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity Natural Medicines 10 927 934 10.1038/nm1091 1:CAS:528:DC%2BD2cXntFSkt7o%3D (Pubitemid 39273733)
79. BM Tesar G Chalasani L Smith-Diggs FK Baddoura FG Lakkis DR Goldstein 2004 Direct antigen presentation by a xenograft induces immunity independently of secondary lymphoid organs Journal of Immunology 173 4377 4386 1:CAS:528:DC%2BD2cXnslWmsbg%3D (Pubitemid 39280666)
80. JE Moyron-Quiroz J Rangel-Moreno L Hartson K Kusser MP Tighe KD Klonowski L Lefrançois LS Cauley AG Harmsen FE Lund TD Randall 2006 Persistence and responsiveness of immunologic memory in the absence of secondary lymphoid organs Immunity 25 643 654 17045819 10.1016/j.immuni.2006.08.022 1:CAS:528:DC%2BD28XhtFemtbvE (Pubitemid 44529043)
81. DL Drayton S Liao RH Mounzer NH Ruddle 2006 Lymphoid organ development: from ontogeny to neogenesis Nature Immunology 7 344 353 16550197 10.1038/ni1330 1:CAS:528:DC%2BD28Xis1Gmuro%3D
82. J Rangel-Moreno D Carragher TD Randall 2007 Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract Inmunologia (Barcelona, Spain : 1987) 26 13 28 (Pubitemid 47025940)
83. CH GeurtsvanKessel MAM Willart IM Bergen LS van Rijt F Muskens D Elewaut ADME Osterhaus R Hendriks GF Rimmelzwaan BN Lambrecht 2009 Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice The Journal of Experimental Medicine 206 2339 2349 19808255 10.1084/jem.20090410 1:CAS:528:DC%2BD1MXhtlCltrjF
84. S Halle HC Dujardin N Bakocevic H Fleige H Danzer S Willenzon Y Suezer G Hämmerling N Garbi G Sutter T Worbs R Förster 2009 Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells The Journal of Experimental Medicine 206 2593 2601 19917776 10.1084/jem.20091472 1:CAS:528:DC%2BD1MXhsV2ltrzL
85. N Cassoux H Merle-Beral V Leblond B Bodaghi D Miléa S Gerber C Fardeau I Reux KH Xuan CC Chan P LeHoang 2000 Ocular and central nervous system lymphoma: clinical features and diagnosis Ocular Immunology and Inflammation 8 243 250 11262654 10.1076/ocii.8.4.243.6463 1:STN:280:DC%2BD3M7mt1Ghtw%3D%3D (Pubitemid 32174745)
86. SE Coupland H Heimann 2004 Primary intraocular lymphoma Der Ophthalmologe 101 87 98 14986704 10.1007/s00347-003-0855-6 1:STN:280:DC%2BD2c%2Fps1KmsA%3D%3D (Pubitemid 38176063)
87. SM Pantanelli Z Li R Fariss SP Mahesh B Liu RB Nussenblatt 2009 Differentiation of malignant B-lymphoma cells from normal and activated T-cell populations by their intrinsic autofluorescence Cancer Research 69 4911 4917 19458079 10.1158/0008-5472.CAN-08-2761 1:CAS:528:DC%2BD1MXmsFGksrc%3D
88. V Touitou C Daussy B Bodaghi S Camelo Y de Kozak P Lehoang M-C Naud A Varin B Thillaye-Goldenberg H Merle-Béral WH Fridman C Sautès-Fridman S Fisson 2007 Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma Investigative Ophthalmology & Visual Science 48 3223 3229 10.1167/iovs.07-0008 (Pubitemid 351261167)
89. EK Akpek I Ahmed FH Hochberg M Soheilian TP Dryja FA Jakobiec CS Foster 1999 Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes Ophthalmology 106 1805 1810 10485554 10.1016/S0161-6420(99)90341-X 1:STN:280:DyaK1MvhtlGltg%3D%3D (Pubitemid 30194285)
90. EK Akpek SM Maca WG Christen CS Foster 1999 Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma Ophthalmology 106 2291 2295 10599659 10.1016/S0161-6420(99)90528-6 1:STN:280:DC%2BD3c%2Fms1KnsA%3D%3D (Pubitemid 30191440)
91. DH Char BM Ljung J Deschênes TR Miller 1988 Intraocular lymphoma: immunological and cytological analysis The British Journal of Ophthalmology 72 905 911 3067746 10.1136/bjo.72.12.905 1:STN:280:DyaL1M7ltVajsQ%3D%3D (Pubitemid 19022865)
92. DH Char BM Ljung T Miller T Phillips 1988 Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management Ophthalmology 95 625 630 3050698 1:STN:280:DyaL1M%2FhsFOjtQ%3D%3D
93. C Corriveau M Easterbrook D Payne 1986 Lymphoma simulating uveitis (masquerade syndrome) Canadian Journal of Ophthalmology 21 144 149 3755372 1:STN:280:DyaL283ntFeltQ%3D%3D (Pubitemid 16059144)
94. SE Coupland B Damato 2008 Understanding intraocular lymphomas Clin Experiment Ophthalmol 36 564 578 18954321 10.1111/j.1442-9071.2008.01843.x
95. F Pagès J Galon M-C Dieu-Nosjean E Tartour C Sautès-Fridman W-H Fridman 2010 Immune infiltration in human tumors: a prognostic factor that should not be ignored Oncogene 29 1093 1102 19946335 10.1038/onc.2009.416